News
Public · Published
HCC: Blue Creek growth powered $139M of free cash flow and a $2/share special dividend
HCC reported third-quarter revenue of $508 million and adjusted EBITDA, a measure of operating earnings, of $124 million, up 76%. Blue Creek drove sales growth and $139 million of free cash flow, which is cash left after spending. HCC also declared a $2 per-share special dividend and reaffirmed FY2026 guidance.
Published:
Updated:
What happened
HCC reported third-quarter revenue of $508 million and adjusted EBITDA, a measure of operating earnings, of $124 million, up 76%. Blue Creek drove sales growth and $139 million of free cash flow, which is cash left after spending. HCC also declared a $2 per-share special dividend and reaffirmed FY2026 guidance.
Confirmed
Global impact / market context
The reported free cash flow gives HCC cash to fund shareholder payments or business needs; the special dividend directs some of it to shareholders now. Blue Creek’s contribution to sales growth and reaffirmed guidance suggest it is central to the company’s stated outlook, though no future results are assured.
Analyst inference
The update combines higher reported revenue and adjusted EBITDA with a one-time shareholder payment, rather than indicating a recurring dividend increase. For investors, Blue Creek’s sales contribution and the company’s ability to generate free cash flow matter because they connect operating performance to cash returns.
Analyst inference
What to watch
- Check subsequent results for whether Blue Creek continues to drive sales growth and whether revenue and adjusted EBITDA sustain the increases reported for the third quarter. Analyst inference
- Compare later results with reaffirmed FY2026 guidance; the article gives no guidance figures, so it does not show how much room remains to meet targets. Analyst inference
- Confirm the timing and payment terms of the $2 per-share special dividend, since the supplied article states it was declared but gives no dates or eligibility details. Analyst inference
Evidence
- Original source link unavailable